Safety of cosmetic dermatologic procedures during pregnancy

Dermatol Surg. 2013 Nov;39(11):1573-86. doi: 10.1111/dsu.12322. Epub 2013 Oct 29.


Background: Safety of cosmetic procedures in pregnant women has not been extensively studied. Maternal and fetal health risks are important to consider in any procedure performed. With the increasing popularity of cosmetic procedures, dermatologic surgeons will be faced with scenarios necessitating knowledge regarding the safety of such procedures during pregnancy. Furthermore, dermatologic surgeons may inadvertently perform cosmetic procedures during the first trimester, before the patient is aware of the pregnancy.

Objective: To investigate the safety of cosmetic procedures during pregnancy and the postpartum period.

Methods and materials: A literature search of PubMed and Google Scholar was conducted of all English-language articles published from 1960 through 2012.

Results: Definitive recommendations on the safety of procedures such as chemical peels, injectables, fillers, and most laser therapies during pregnancy cannot be made. The safety of onabotulinum toxin usage is well documented in the neurology literature, although isolated events of miscarriage have been reported with high doses of toxin in women with a previous history of miscarriage. Carbon dioxide laser therapy for genital condylomas has considerable evidence supporting its safety during pregnancy.

Conclusion: There is a lack of controlled trials addressing the safety of cosmetic procedures during pregnancy and postpartum periods. It is advisable to delay elective cosmetic procedures until after the baby is born.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Blood Coagulation / physiology
  • Cosmetic Techniques* / adverse effects
  • Dermatologic Agents / pharmacokinetics
  • Dermatologic Agents / therapeutic use
  • Dermatologic Surgical Procedures* / adverse effects
  • Elective Surgical Procedures
  • Electrocoagulation
  • Female
  • Hemangioma / therapy
  • Humans
  • Lactation
  • Milk, Human / drug effects
  • Neurotransmitter Agents / therapeutic use
  • Patient Safety
  • Pregnancy* / physiology


  • Anti-Bacterial Agents
  • Dermatologic Agents
  • Neurotransmitter Agents